Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Jun 13, 2016 8:52 AM ET

ProMIS Neurosciences, Inc.: Our mission is to discover and develop precision medicine therapeutics for disease modifying treatment of neurodegenerative diseases, in particular Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS)


iCrowd Newswire - Jun 13, 2016

ProMIS Neurosciences, Inc.
Location: Toronto, Ontario Sector: Life Science

Our mission is to discover and develop precision medicine therapeutics for disease modifying treatment of neurodegenerative diseases, in particular Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).As its primary objective, the Company will focus on the discovery and development of specific therapeutics and companion diagnostics directed against the several strains of misfolded (prion-like) Amyloid beta (Aβ) in Alzheimer’s.

MG cp Summary

 

 

Youtube Link:

Contact Information:

Elliot P Goldstein








Tags:    Crowdfunding, Equity Crowdfunding, North America, English